Scientists have made monumental strides in their quest to protect vulnerable babies from respiratory syncytial virus (RSV): ...

The journey toward an RSV vaccine for children has been wrought with tragedy and setbacks. But six decades after scientists embarked on that path, they are nearing the finish line ...

Vaccines are usually administered with a needle poke into the arm. But what if instead of a poke, you could get vaccinated ...

Sanofi (($SNYNF)) announced an update on their ongoing clinical study. Sanofi has launched a Phase 1 clinical study titled ‘A Phase 1, Parallel, ...

RSV vaccines will be available for high-risk residents by early October, including all adults aged 75 and older. Eligible residents should get their RSV dose as early as possible to get protection ...

Who should get it: Though the official recommendation from the CDC has been lifted, health providers generally recommend the COVID vaccine for anyone aged six months and older.

“You take the virus, grow it up, purify it and kill it with an inactivating agent. That’s a whole-killed viral vaccine,” said Dr. Paul Offit, director of the Vaccine Education Center at the Children’s ...

At first, Ethel Branch thought her two-year-old son, Patro, had a cold or maybe the flu. Frantic, Branch rushed Patro to the ...

With no specific treatment and only partial natural immunity, experts emphasised proactive prevention through hygiene and new ...

Death rates among hospitalized patients were 8.9% to 10.4%, and annual adjusted costs were $32 million to $90 million, mainly ...

Key PointsNasal vaccines trigger mucosal immune responses, in addition to systemic responses elicited by traditional vaccines ...